Abstract
Biotechnology startup companies are often based on little more than a technology with the potential to contribute to the development of innovative products in the future. Failure of this technology leads to a life-threatening crisis for these firms; managers must react quickly to ensure survival of their companies. The existing literature does not provide information on how biotechnology startups successfully escape technology breakdown crises. In this work, we present an in-depth case study of a biopharmaceutical startup company that suffered and successfully escaped a technology breakdown crisis. We illustrate its project acquisition strategy as well as management of financial, organisational, human and social resources after the breakdown. Our findings have implications for managers of entrepreneurial biotechnology firms.
Original language | English |
---|---|
Pages (from-to) | 244-264 |
Number of pages | 21 |
Journal | International Journal of Biotechnology |
Volume | 8 |
Issue number | 3-4 |
DOIs | |
State | Published - 2006 |
Externally published | Yes |
Keywords
- Biotechnology
- Case study
- Crisis management
- Entrepreneurship
- Financing
- Investor relations
- Management
- Start-up
- Technology
- Venture capital